{"nct_id":"NCT03086369","title":"A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2017-06-22","start_date_type":"ACTUAL","primary_completion_date":"2021-01-05","primary_completion_date_type":"ACTUAL","completion_date":"2021-06-17","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["LLY"]}